What Xalico is and what it is used for?
The name of your medicine is Xalico. The active ingredient of Xalico is Oxaliplatin. Xalico is used to treat cancer of the large bowel (treatment of stage III colon cancer after complete resection of primary tumour, metastatic cancer of colon and rectum). Xalico is used in combination with other anticancer medicines called 5-fluorouracil and folinic acid. Xalico has to be diluted before it can be injected into a vein.
Oxaliplatin is an antineoplastic or anticancer drug and contains platinum
What you need to know before you use Xalico
Do not use Xalico if:
Warnings and precautions
Talk to your doctor or pharmacist before taking Xalico:
Children and adolescents
Xalico should not be used in children and adolescents below 18 years of age.
Other medicines and Xalico
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including vaccines.
Pregnancy, breast-feeding and fertility
Pregnancy
Xalico must NOT be administered if you are pregnant unless clearly indicated by your doctor.
Breast-feeding
You must not breast-feed while you are treated with oxaliplatin, because it is not known if Xalico passes into breast milk. Due to the possibility of harm to the infant stop breast-feeding and do not restart breast-feeding unless your doctor has allowed you to.
Fertility
Xalico may have an anti-fertility effect, which could be irreversible. Male patient should seek advice on conservation of sperm prior to treatment.
Male patients are advised not to father a child during treatment and until 6 months after treatment and to take appropriate contraceptive measures during this time.
to seek advice
Driving and using machines
Oxaliplatin treatment may result in an increased risk of dizziness, nausea and vomiting, and other neurological symptoms that affect walking and balance.
If this happens you should not drive or operate machinery. If you have vision problems while taking Xalico, do not drive, use heavy machines, or engage in dangerous activities.
How to use Xalico?
For adults only.
Xalico is intended only for adults.
Dosage
The dose of Xalico is based on your body surface area. This is calculated from your height and weight. The usual dose for adults including the elderly is 85 mg/m2 of body surface area. The dose you receive will also depend on results of blood tests and whether you have previously experienced side effects with Xalico.
Method and route of administration:
From a microbiological point of view, the infusion preparation should be used immediately.
If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 °C to 8 °C unless dilution has taken place in controlled and validated aseptic conditions.
Frequency of administration:
You should usually receive your infusion once every 2 weeks.
Duration of treatment:
The duration of the treatment will be determined by your doctor. Your treatment will last a maximum of 6 months when used after complete resection of your tumour.
If you are given more Xalico than you should:
As this medicine is administered by a healthcare professional it is highly unlikely that you will be given too much or too little. In case of overdose, you may experience increased side effects.
Your doctor may give you appropriate treatment for these side effects.
If you have any questions about your treatment, ask your doctor, nurse or pharmacist.
Possible side effects
Like all medicines, Xalico can cause side effects, although not everybody gets them.
If you experience any side effect it is important that you inform your doctor before your next treatment.
You will find described below the side effects that you could experience.
Tell your doctor immediately if you notice any of the following:
Other known side effects of Oxaliplatin are:
Very common (may affect more than 1 in 10 people):
Xalico can affect the nerves (peripheral neuropathy). You may feel a tingling and/or numbness in the fingers, toes, around the mouth or in the throat, which may sometimes occur in association with cramps.
These effects are often triggered by exposure to cold e.g. opening a refrigerator or holding a cold drink. You may also have difficulty in performing delicate tasks, such as buttoning clothes. Although in the majority of cases these symptoms resolve themselves completely, there is a possibility of persistent symptoms of peripheral sensory neuropathy after the end of the treatment. Some people have experienced a tingling, shock-like sensation passing down the arms or trunk when the neck is flexed.
Your doctor may decide to alter your treatment as a result.
Your doctor will take blood to check that you have sufficient blood cells before you start treatment and before each subsequent course.
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Not known (frequency cannot be estimated from the available data):
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.
By reporting side effects, you can help provide more information on the safety of this medicine.
How to store Xalico
Keep out of the sight and reach of children.
Store below 30°C. Keep vial in outer carton in order to protect from light.
Protect from freezing.
Once diluted the infusion preparation should be used immediately. If not used immediately, store in a refrigerator (2 to 8°C) for no more than 24 hours.
Chemical and physical in use stability has been demonstrated for 24 hours at 2°C to 8°C and 6 hours at 25°C.
From a microbiological point of view, the infusion preparation should be used immediately. If not used immediately, in-use storage times and conditions are the responsibility of the user and would not normally be longer than 24 Hours at 2°C to 8°C, unless dilution has taken place in controlled and validated aseptic conditions.
Do not use this medicine if you notice that the solution is not clear and free of particles.
Do not use this medicine after the expiry date which is stated on the label and carton.
For single-used only. Discard unused portion.
Xalico should not come into contact with the eyes or skin. If there is any accidental spillage, tell the doctor or nurse immediately.
The medicine should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
Further information
What Xalico contains
Xalico contains the active substance oxaliplatin.
Each ml of concentrate for solution for infusion contains 5 mg oxaliplatin.
10 ml of concentrate for solution for infusion contains 50 mg oxaliplatin.
20 ml of concentrate for solution for infusion contains 100 mg oxaliplatin
The other ingredient is water for injection.
What Xalico looks like and contents of the pack
Xalico is in the form of concentrate solution for infusion a concentrated solution which is diluted to make a solution which can be given as a slow infusion via a drip).
Each milliliter (ml) of solution contains 5 milligrams (mg) of oxaliplatin. It is a clear, colorless solution contained in glass containers called vials, containing 50 mg (10 ml) and 100 mg (20 ml) of oxaliplatin. The vials are available in single packs;
1 x 50 mg /10 ml vial
1 x 100 mg /20 ml vial
The solution is then diluted in glucose 5% solution and can be given as an infusion via a drip.